Targeted genome editing restores auditory function in adult mice with progressive hearing loss caused by a human microRNA mutation is a research paper published in Science Translational Medicine (2024). On theSindex it has a DataRank of 0. It has been cited 24 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 5R01DC005575-09
Molecular Genetics of Non-Syndromic Deafness
National Institutes of Health
Grant: 5UG3TR002636-02
Efficient in Vivo RNP-based Gene Editing in the Sensory Organ Inner Ear Using Bioreducible Lipid Nanoparticles
National Institutes of Health
Grant: 5U24HG010423-02
Dissemination and Coordinating Center for the SCGE Consortium
Wellcome Trust
Grant: 098051
Wellcome Trust Sanger Institute - generic account for deposition of all core- funded research papers
National Institutes of Health
Grant: 5R01DC016875-04
Development of Genome Editing as Treatment for Genetic Hearing Loss
National Institutes of Health
Grant: 5R01DC019404-03
Development of CRISPR/Cas9-based exon-skipping strategies for the treatment of USH-associated deafness
National Institutes of Health
Grant: 2R01DC012115-06A1
Implementing genomic medicine in clinical care of deaf patients
Fields of Study
Keywords